Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Net Margin (2023 - 2025)

Mangoceuticals' Net Margin history spans 3 years, with the latest figure at 9392.46% for Q3 2025.

  • For Q3 2025, Net Margin fell 789308.0% year-over-year to 9392.46%; the TTM value through Sep 2025 reached 4308.49%, down 307317.0%, while the annual FY2024 figure was 1413.8%, 15440.0% down from the prior year.
  • Net Margin for Q3 2025 was 9392.46% at Mangoceuticals, down from 3221.61% in the prior quarter.
  • Across five years, Net Margin topped out at 733.99% in Q3 2023 and bottomed at 9392.46% in Q3 2025.
  • The 3-year median for Net Margin is 1617.16% (2023), against an average of 2628.04%.
  • The largest annual shift saw Net Margin skyrocketed 143666bps in 2024 before it crashed -789308bps in 2025.
  • A 3-year view of Net Margin shows it stood at 1050.87% in 2023, then tumbled by -76bps to 1851.45% in 2024, then tumbled by -407bps to 9392.46% in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Net Margin are 9392.46% (Q3 2025), 3221.61% (Q2 2025), and 4427.47% (Q1 2025).